Comparison of Effectiveness and Safety of Ranolazine Versus Amiodarone for Preventing Atrial Fibrillation After Coronary Artery Bypass Grafting
- 1 September 2011
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 108 (5), 673-676
- https://doi.org/10.1016/j.amjcard.2011.04.017
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The Conversion of Paroxysmal or Initial Onset Atrial Fibrillation with Oral Ranolazine: Implications for a New "Pill-In-Pocket" Approach in Structural Heart DiseaseJournal of Atrial Fibrillation, 2010
- Effect of Ranolazine, an Antianginal Agent With Novel Electrophysiological Properties, on the Incidence of Arrhythmias in Patients With Non–ST-Segment–Elevation Acute Coronary SyndromeCirculation, 2007
- Atrium-Selective Sodium Channel Block as a Strategy for Suppression of Atrial FibrillationCirculation, 2007
- Oxidative Stress Markers Are Associated with Persistent Atrial FibrillationClinical Chemistry, 2007
- Ranolazine Improves Abnormal Repolarization and Contraction in Left Ventricular Myocytes of Dogs with Heart Failure by Inhibiting Late Sodium CurrentJournal of Cardiovascular Electrophysiology, 2006
- The mechanism of ranolazine action to reduce ischemia-induced diastolic dysfunctionEuropean Heart Journal Supplements, 2006
- Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic PropertiesCirculation, 2004
- 1115-72 Aggressive treatment of atrial fibrillation reduces stoke following cardiac surgeryJournal of the American College of Cardiology, 2004
- Adverse Effects of AmiodaronePacing and Clinical Electrophysiology, 1998
- Alterations in electrical and contractile behavior of isolated cardiomyocytes by hydrogen peroxide: Possible ionic mechanismsJournal of Molecular and Cellular Cardiology, 1991